SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000921895-12-001508
Filing Date
2012-07-16
Accepted
2012-07-16 12:31:52
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g07422qlt_07052012.htm SC 13G 195498
2 JOINT FILING AGREEMENT ex991to13g07422qlt_07052012.htm EX-99.1 27916
  Complete submission text file 0000921895-12-001508.txt   225149
Mailing Address 887 GREAT NORTHERN WAY VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY - VANCOUVER A1 V5T 4T5 6047077000
QLT INC/BC (Subject) CIK: 0000827809 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-43381 | Film No.: 12963309
SIC: 2834 Pharmaceutical Preparations

Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice